The main shareholder of Credit Suisse has ruled out providing more financial assistance to the ailing Swiss bank, prompting its share prices to drop to new record lows.
This content was published on
2 minutes
Reuters/Bloomberg/SWI/ug
Italiano
it
Il prestatore saudita è ottimista sul Credit Suisse, ma il titolo scende a un nuovo minimo storico
Saudi Arabia’s National Bank, which acquired 9.88% of Credit Suisse shares last year, said it would not buy more shares on regulatory grounds.
“We cannot because we would go above 10%. It’s a regulatory issue,” Saudi National Bank chairman, Ammar Al Khudairy said on the sidelines of a conference in the Saudi capital, Riyadh, on Wednesday.
His comments came as the price of Credit Suisse shares for the first time dropped below CHF2 ($2.18).
The shares of Switzerland’s second biggest bank slid as much as 30% in trading on Wednesday, sparking a broader sell-off in European and United States stocks.
Credit Suisse shares recovered slightly later in the day and closed at CHF1.697 on the Zurich stock exchange.
The European Central Bank reportedly contacted lenders to ask about financial exposures to Credit Suisse , while the United States Treasury said it was monitoring the situation closely.
The slump also prompted action by politicians, notably in France.
Nerves
In a bid to calm nerves, the Credit Suisse chief executive, Ulrich Körner, said the bank’s liquidity base remained strong and was well above all regulatory requirements.
The bank asked the Swiss National Bank (SNB) and the Swiss financial regulator for a public show of support, the Reuters news agency reported.
However, the SNB declined to comment.
The Credit Suisse chairman, Axel Lehmann, is quoted as saying government assistance “isn’t a topic” for the bank as it seeks to shore up confidence among clients, investors and regulators after a series of missteps.
Saudi optimism
The chairman of Saudi Arabia’s National Bank said earlier that the Saudi investment objective is not dependent on time.
Al Khudairy said the value realisation of that investment will unfold as the Swiss bank proves they are doing the turnaround.
“We are happy with the plan, the transformation plan that they have put forward. It is a very strong bank,” he said.
“I don’t think they will need extra money; if you look at their ratios, they’re fine. And they operate under a strong regulatory regime in Switzerland and in other countries,” he told the Reuters news agency.
Credit Suisse is battling to recover from a string of scandals that have undermined the confidence of investors and clients.
More
More
Where did it all go wrong for Credit Suisse?
This content was published on
A roadmap of scandals that have led Credit Suisse to massive losses and restructuring cuts.
Has your continent reached its peak or is there still potential for economic growth?
Some regions of the world are on an upward trajectory with the promise of a steadily improving future. Where do you live? And in which direction is your region or continent developing?
This content was published on
There is no longer any danger of rockfall or landslide on the roads below the village of Brienz, canton Graubünden, authorities say.
This content was published on
Europe’s biggest freshwater fish tastes better than its reputation, say fishermen in the French-speaking west of Switzerland.
Swiss authorities keep close eye on West Nile fever in Italy
This content was published on
Authorities are keeping a close eye on the situation after the death toll in Italy due to the disease has risen to seven.
Bern biodiversity project brings boost for forest bees
This content was published on
More sunlit areas in forests can boost the number of wild bees – both in overall terms and in terms of species diversity.
Swiss president kicks off National Day celebrations on Rütli meadow
This content was published on
Several hundred people gathered on the Rütli in central Switzerland at midday on Friday to celebrate the national Swiss holiday, before Karin Keller-Sutter addressed the crowd.
US sets deadline for Novartis and other pharma firms to lower prices
This content was published on
US President Donald Trump says he has sent letters to Swiss giant Novartis and other pharma firms calling for lower drug prices in the United States – or face retaliation.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Credit Suisse slashes bonuses after disastrous year
This content was published on
Credit Suisse bank has cut staff bonuses by half, with none being awarded to top managers, following a disastrous CHF7.3 billion loss.
Former top Credit Suisse shareholder Harris Associates sells out of bank
This content was published on
One of Credit Suisse’s longest-standing shareholders has sold its entire stake amid persistent losses and a client exodus.
Credit Suisse slammed for ‘serious breaches’ in Greensill debacle
This content was published on
Swiss financial regulator finds Credit Suisse “seriously breached its supervisory obligations” in its dealings with the collapsed Greensill Capital.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.